Amicus Therapeutics Inc
* Amicus Therapeutics- Submitted Japanese NDA to Pharmaceuticals and Medical Devices Agency to request marketing authorization for migalastat
* Amicus Therapeutics Inc - based on priority review timeline, Amicus expects a decision from PMDA in first half of 2018 Source text for Eikon: Further company coverage:
